Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Spyre Therapeutics (SYRE) Tax Provisions: 2021-2024

Historic Tax Provisions for Spyre Therapeutics (SYRE) over the last 4 years, with Dec 2024 value amounting to $51,000.

  • Spyre Therapeutics' Tax Provisions fell 146.88% to -$15,000 in Q1 2025 from the same period last year, while for Mar 2025 it was $36,000, marking a year-over-year increase of 500.00%. This contributed to the annual value of $51,000 for FY2024, which is 296.15% up from last year.
  • Spyre Therapeutics' Tax Provisions amounted to $51,000 in FY2024, which was up 296.15% from -$26,000 recorded in FY2023.
  • Spyre Therapeutics' 5-year Tax Provisions high stood at $141,000 for FY2021, and its period low was -$136,000 during FY2022.
  • Its 3-year average for Tax Provisions is -$37,000, with a median of -$26,000 in 2023.
  • Its Tax Provisions has fluctuated over the past 5 years, first crashed by 196.45% in 2022, then spiked by 296.15% in 2024.
  • Yearly analysis of 4 years shows Spyre Therapeutics' Tax Provisions stood at $141,000 in 2021, then plummeted by 196.45% to -$136,000 in 2022, then surged by 80.88% to -$26,000 in 2023, then skyrocketed by 296.15% to $51,000 in 2024.